COPD News Today: Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show
02/07/20
Remestemcel-L, Mesoblast’s lead candidate stem cell therapy for inflammatory diseases, improves lung function and exercise capacity in people with chronic obstructive pulmonary disease (COPD) and a high degree of inflammation, data from a post-hoc analysis of a Phase 2 trial show. Findings were presented in an oral presentation at the 2020 International Society for Cell & Gene Therapy (ISCT) annual meeting, which […]
The coronavirus disease (COVID-19) has ravaged across the, infecting more than 3.11 million people in just over four months. As the virus continues to spread, scientists are struggling to find an effective treatment for the infection. Now, a breakthrough discovery on stem cells could help in the battle against COVID-19. Researchers at Lund University in Sweden have […]
